600557.SH
康缘药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 11.91
−1.24%Margins
Gross margin
71.6%
EBITDA margin
17.5%
EBIT margin
11.2%
Net margin
9.2%
FCF margin
-0.4%
6.1%
Return on equity
4.4%
Return on assets
7.4%
Return on invested capital
0.47x
Asset turnover
CNY 599.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026